Research institutes CARIM header image

Cardiovascular Research Institute Maastricht

CARIM is one of the top institutes for translational cardiovascular research in Europe. It is among the world leaders in the fields of research into vascular and thrombotic disorders and atrial fibrillation, as well as translational heart failure research. It has also made important international contributions to molecular imaging in the cardiovascular field.

Cardiovascular scientists from around the world have joined CARIM because it values open communication, close cooperation, high ambitions, excellent facilities, and a critical learning environment. 

Research

The research within CARIM is divided into three divisions. Each division consists of more interdisciplinary research programmes, each led by a Principal Investigator (PI). The PIs are responsible for the scientific progress of the programme, the mentoring of PhD students and post-docs, and the financials of the programme.
 

Education

CARIM combines high-level scientific research with high-level education of young researchers, and is therefore qualified as a research school by the Royal Netherlands Academy of Arts and Sciences (KNAW) and recognised as an international training site for Early Stage Researchers by the European Union.

CARIM offers a flexible and integrated education and training programme that suits individual ambitions of our students. The education programme consists of a specialization within the FHML master's programmes in Biomedical Sciences and Physician-Clinical Investigator  (MSc/MD) and a contiguous PhD (doctoral) training programme. 

Divisions

The three divisions within CARIM are:

  • Blood
  • Heart
  • Vessels

International research collaboration aims to personalise prevention and treatment of cardiovascular diseases

International research collaboration aims to personalise prevention and treatment of cardiovascular diseases

Diabetic heart failure

Making impact with a digital twin heart

At the CARIM research institute (school for cardiovascular diseases) in Maastricht, a group of researchers – led by Joost Lumens - is working with ‘het digitale tweelinghart’ (the digital twin heart): a computer model that simulates the human heart. This research gives rise to a great deal of...

Placeholder

Safe research unravels heart diseases

With the Maastricht CardioMyoPathy Register, researchers are exploring new possibilities for the detection and treatment of heart diseases. Using an innovative database, they ensure the security of participants' data.

henkens

Saving more lives with less money

Roger Rennenberg is not aiming for a spectacular new treatment that makes the headlines. However, ambition is not lacking because by focusing on improving the quality and safety of healthcare, he wants to save more lives with less money. With his inaugural speech titled "Healthcare of the highest...

Placeholder

Chahinda Ghossein named Top Woman Limburg 2022

Chahinda Ghossein has been named Top Woman Limburg 2022. She conducts research on cardiovascular diseases in women, particularly in relation to their pregnancy. She is committed to this women-specific issue through her work as a cardiologist and scientist.

Chahinda Ghossein

CARIM works in close cooperation with the Maastricht University Medical Center+ (MUMC+). MUMC+ is known both nationally and internationally for its focus on prevention and taking an integrated approach to health care: from prevention, promotion of good health, and basic care, to top-level clinical diagnostics and treatment. Patient safety is our top priority in all of our endeavours. MUMC+ is part of The Netherlands Federation of University Medical Centres.

Maastricht University Medical Center (MUMC+) logo